| Field | Specification |
|---|---|
| Alternative names | CAS9-C57PCAEC |
| Species | |
| Applications | |
| Cell type | |
| Classification | |
| Tissue | |
| Growth properties | |
| Biosafety level | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Overview
Cas9-Expressing C57BL/6 Mouse Primary Carotid Artery Endothelial Cells are primary endothelial cells derived from mouse c57bl/6 carotid tissue. Product metadata indicate adherent growth with endothelial morphology and a reported BSL-2 handling context. Depending on the selected variant, the product may be supplied in selectable cryopreserved formats (Frozen Vial (0.5 x 10^6 cells)) for in vitro studies that benefit from tissue-relevant cellular context.
Key elements and design rationale
- Source and identity reflect the stated endothelial cells model and tissue origin, supporting experiments where c57bl/6 carotid/cardiovascular context matters.
- Reported classifications and phenotype descriptors include primary, adherent growth, and endothelial morphology.
- Selectable variants can include Frozen Vial (0.5 x 10^6 cells); choose the listed format according to culture scale, handling preference, and downstream assay design.
- Handling considerations should follow institutional practice appropriate for the reported BSL-2 classification and the datasheet associated with the selected format.
Review the specification table and variant selector together when choosing the appropriate format for assay scale, tissue context, and downstream readouts.
Biological background
Endothelial cells line blood and lymphatic vessels and are central to barrier regulation, leukocyte trafficking, angiogenesis, coagulation signaling, and responses to shear or inflammatory cues. Tissue of origin can influence transport properties, junctional organization, and activation state. In this case, the stated c57bl/6 carotid tissue and cardiovascular context can influence morphology, baseline signaling, and assay responsiveness.
Research relevance and current trends
- Vascular biology remains an active area for experiments that compare tissue-specific phenotype, pathway response, or functional readouts in culture-based systems.
- Multiparametric readouts such as cell culture, imaging, and immunofluorescence are commonly combined to connect morphology, phenotype, and pathway-level response.
- Comparisons across donor source, passage, tissue origin, or model state can help separate model-specific effects from assay-specific effects.
Common research applications
- Cell culture and condition-optimization studies to assess morphology, growth behavior, or baseline phenotype over time.
- Imaging-based workflows to track morphology, localization, marker expression, cell-cell interactions, or reporter-linked signal.
Changes in morphology, marker expression, proliferation, migration, barrier properties, reporter activity, or secreted factors are typically interpreted alongside matched controls and the selected culture conditions.
Notes for experimental interpretation
- Potential confounders include donor-to-donor variability, passage-dependent phenotypic drift, substrate effects, serum or media composition, and differences between cryopreserved and expansion-stage material.
- Use matched controls and confirm identity with morphology- and marker-based readouts suited to the stated cell type, tissue source, and downstream assay.
- The product title indicates a Cas9-expressing configuration, which can be relevant for genome-editing or perturbation studies when used with matched guide RNA workflows.
Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
